BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22906929)

  • 21. [Hedgehog inhibitors. New promising treatment of advanced basal cell carcinoma].
    Wolodarski M; Lapins J; Hansson J
    Lakartidningen; 2013 Apr 24-May 6; 110(17-18):886-8. PubMed ID: 23717940
    [No Abstract]   [Full Text] [Related]  

  • 22. Hedgehog signaling and therapeutics in pancreatic cancer.
    Kelleher FC
    Carcinogenesis; 2011 Apr; 32(4):445-51. PubMed ID: 21186299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basal cell carcinoma rebound after cessation of vismodegib in a nevoid basal cell carcinoma syndrome patient.
    Wolfe CM; Green WH; Cognetta AB; Hatfield HK
    Dermatol Surg; 2012 Nov; 38(11):1863-6. PubMed ID: 22805146
    [No Abstract]   [Full Text] [Related]  

  • 24. Hedgehog pathway in sarcoma: from preclinical mechanism to clinical application.
    Banaszek N; Kurpiewska D; Kozak K; Rutkowski P; Sobczuk P
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17635-17649. PubMed ID: 37815662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the Hedgehog pathway in lung cancer.
    Dimou A; Bamias A; Gogas H; Syrigos K
    Lung Cancer; 2019 Jul; 133():56-61. PubMed ID: 31200829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of inoperable advanced basal cell carcinoma: the economic, physical, and psychological burden of the disease.
    Haves AW; Schaffer PR; Carucci JA
    J Drugs Dermatol; 2013 Oct; 12(10 Suppl):s151-3. PubMed ID: 24085061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A frequent activated smoothened mutation in sporadic basal cell carcinomas.
    Lam CW; Xie J; To KF; Ng HK; Lee KC; Yuen NW; Lim PL; Chan LY; Tong SF; McCormick F
    Oncogene; 1999 Jan; 18(3):833-6. PubMed ID: 9989836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smoothened Inhibitors in Sonic Hedgehog Subgroup Medulloblastoma.
    Ransohoff KJ; Sarin KY; Tang JY
    J Clin Oncol; 2015 Aug; 33(24):2692-4. PubMed ID: 26195713
    [No Abstract]   [Full Text] [Related]  

  • 29. Basal cell carcinoma, Hedgehog signaling, and targeted therapeutics: the long and winding road.
    Wong SY; Dlugosz AA
    J Invest Dermatol; 2014 Oct; 134(e1):E18-22. PubMed ID: 25302468
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanisms and efficacy of vismodegib in the treatment of basal cell carcinoma.
    Amin SH; Motamedi KK; Ochsner MC; Song TE; Hybarger CP
    Discov Med; 2013 Nov; 16(89):229-32. PubMed ID: 24229739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hedgehog signaling pathway and human disorders].
    Fujii K; Miyashita T
    No To Hattatsu; 2009 Jul; 41(4):247-52. PubMed ID: 19618878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smoothened antagonists: a promising new class of antitumor agents.
    Gallinari P; Filocamo G; Jones P; Pazzaglia S; Steinkühler C
    Expert Opin Drug Discov; 2009 May; 4(5):525-44. PubMed ID: 23485085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study.
    Italiano A; Le Cesne A; Bellera C; Piperno-Neumann S; Duffaud F; Penel N; Cassier P; Domont J; Takebe N; Kind M; Coindre JM; Blay JY; Bui B
    Ann Oncol; 2013 Nov; 24(11):2922-6. PubMed ID: 24170610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GANT-61 induces cell cycle resting and autophagy by down-regulating RNAP III signal pathway and tRNA-Gly-CCC synthesis to combate chondrosarcoma.
    Sun Y; Fang Q; Liu W; Liu Y; Zhang C
    Cell Death Dis; 2023 Jul; 14(7):461. PubMed ID: 37488121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Implications of Hedgehog Pathway Signaling in Prostate Cancer.
    Suzman DL; Antonarakis ES
    Cancers (Basel); 2015 Sep; 7(4):1983-93. PubMed ID: 26426053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [in process].
    Bruhn C
    Med Monatsschr Pharm; 2017 May; 40(5):221-2. PubMed ID: 29952153
    [No Abstract]   [Full Text] [Related]  

  • 37. The mosaic hedgehog spectrum: another lesson on the polymorphy of mosaicism.
    Zenker M
    Br J Dermatol; 2020 Jan; 182(1):22-23. PubMed ID: 31494922
    [No Abstract]   [Full Text] [Related]  

  • 38. BCC identity switch breaks restraints of Hedgehog pathway inhibition.
    Killock D
    Nat Rev Clin Oncol; 2018 Dec; 15(12):724. PubMed ID: 30353109
    [No Abstract]   [Full Text] [Related]  

  • 39. Note on the Ovarian Ova of the Hedgehog.
    Carlier EW
    J Anat Physiol; 1899 Jan; 33(Pt 2):304-8. PubMed ID: 17232375
    [No Abstract]   [Full Text] [Related]  

  • 40. Blocking signaling at the level of GLI regulates downstream gene expression and inhibits proliferation of canine osteosarcoma cells.
    Shahi MH; Holt R; Rebhun RB
    PLoS One; 2014; 9(5):e96593. PubMed ID: 24810746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.